Independent Advisor Alliance Acquires 5,518 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Independent Advisor Alliance grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 16.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 38,828 shares of the pharmacy operator’s stock after purchasing an additional 5,518 shares during the period. Independent Advisor Alliance’s holdings in Walgreens Boots Alliance were worth $362,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. First Financial Corp IN grew its position in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC lifted its position in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $11.17 on Wednesday. The business’s fifty day moving average is $10.89 and its 200 day moving average is $9.79. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a market capitalization of $9.65 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.66 EPS. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of research analyst reports. Royal Bank of Canada lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.